Allogene Therapeutics, Inc. Financial Ratios — ALLO Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	-27.71	-37.03	-18.16	-42.76	-55.51	-55.13	-53.42
Return on Assets (%)	- -	-54.66	-24.75	-32.52	-15.98	-36.36	-44.7	-43.24	-39.58
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	100	100	100	- -
EBITDA Margin (%)	- -	- -	- -	- -	-148.78	-205,923.72	-316,097.89	-1,108,377.27	- -
Operating Margin (%)	- -	- -	- -	- -	-157.94	-215,087.18	-331,044.21	-1,170,372.73	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-229,768.18
Pretax Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,168,850	- -
Profit Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,170,863.64	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,170,863.64	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	-27.71	-37.03	-18.16	-42.76	-55.51	-55.13	-53.42

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	34	53	54	73	101	95	91	83
ST Debt	- -	- -	2	3	3	6	7	8	8
LT Debt	- -	34	51	51	70	95	88	83	75
Total Debt/EBITDA	- -	-0.18	-0.27	-0.21	-0.43	-0.31	-0.32	-0.37	-0.43
Net Debt/EBITDA	- -	0.48	0.89	0.73	1.02	0.19	0.28	0.31	0.27
Total Debt/EBIT	- -	-0.18	-0.26	-0.21	-0.41	-0.3	-0.3	-0.35	-0.4
Net Debt/EBIT	- -	0.48	0.87	0.71	0.96	0.18	0.26	0.29	0.25
EBITDA to Interest Expense	- -	-56.98	- -	- -	- -	- -	- -	-1,347.2	-181
EBITDA-CapEx/Interest Expense	- -	-57.94	- -	- -	- -	- -	- -	-1,351.03	-181.36
EBIT to Interest Expense	- -	-57.43	- -	- -	- -	- -	- -	-1,422.55	-192.5
Interest Expense	- -	3	- -	- -	- -	- -	- -	- -	1
Common Equity/Total Assets	- -	90.87	87.63	87.93	88.04	81.17	79.68	76.94	70.34
Long-Term Debt/Equity (%)	- -	4.9	8.16	4.71	7.56	14.26	17.25	19.72	25.65
Long-Term Debt/Capital (%)	- -	4.67	7.53	4.48	7	12.39	14.55	16.23	19.97
Long-Term Debt/Total Assets (%)	- -	4.45	7.15	4.14	6.65	11.58	13.74	15.17	18.04
Total Debt/Equity (%)	- -	4.9	8.43	4.98	7.9	15.16	18.57	21.5	28.46
Total Debt/Capital (%)	- -	4.67	7.77	4.75	7.33	13.17	15.66	17.69	22.15
Total Debt/Total Assets (%)	- -	4.45	7.39	4.38	6.96	12.31	14.8	16.54	20.02
Net Debt to Equity	- -	-13.15	-27.84	-16.98	-18.73	-9.28	-16.23	-17.82	-17.67
Net Debt/Capital (%)	- -	-14.33	-34.55	-19.3	-21.01	-8.77	-15.86	-17.18	-15.95
EBITDA	- -	-191	-197	-251	-170	-321	-300	-244	-195
EBITDA-CapEx	- -	-195	-248	-317	-191	-326	-302	-245	-195
Operating Income (Loss)	- -	-193	-202	-258	-180	-336	-314	-257	-207

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	15.59	16.04	8.78	9.55	9.63	12.1	8.23	7.7
Current Ratio	- -	15.89	16.46	8.96	9.84	9.84	12.38	8.54	7.93
Quick Ratio	- -	15.7	16.11	8.78	9.55	9.63	12.1	8.23	7.7
CFO/Avg Current Liab	- -	-3.03	-4.39	-1.81	-2.6	-4.34	-5.24	-5.52	-4.39
Common Equity/Total Assets	- -	90.87	87.63	87.93	88.04	81.17	79.68	76.94	70.34
Long-Term Debt/Equity (%)	- -	4.9	8.16	4.71	7.56	14.26	17.25	19.72	25.65
Long-Term Debt/Capital (%)	- -	4.67	7.53	4.48	7	12.39	14.55	16.23	19.97
Long-Term Debt/Total Assets (%)	- -	4.45	7.15	4.14	6.65	11.58	13.74	15.17	18.04
Total Debt/Equity (%)	- -	4.9	8.43	4.98	7.9	15.16	18.57	21.5	28.46
Total Debt/Capital (%)	- -	4.67	7.77	4.75	7.33	13.17	15.66	17.69	22.15
Total Debt/Total Assets (%)	- -	4.45	7.39	4.38	6.96	12.31	14.8	16.54	20.02
CFO/Total Liabilities	- -	-63.17	-154.71	-77.65	-147.11	-142.55	-182.03	-158.3	-120.98
CFO/CapEx	- -	-13.81	-2.7	-1.74	-8.62	-42.48	-156.82	-288.62	-386.65
Altman's Z-Score	- -	27.24	20.97	13.66	9	0.77	-1.74	-3.46	-6.23

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	3,272	3,228	3,546	2,128	909	541	452	314
- Cash & Cash Equivalents	- -	92	175	183	173	62	83	75	52
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	34	53	54	73	101	95	91	83
Enterprise Value	- -	2,847	2,751	2,771	1,744	492	188	250	147
Total Capital	- -	738	682	1,133	998	768	607	513	376
Total Debt/Capital (%)	- -	4.67	7.77	4.75	7.33	13.17	15.66	17.69	22.15
Total Debt / EV	- -	0.01	0.02	0.02	0.04	0.21	0.51	0.36	0.57
EV/Sales	- -	- -	- -	- -	15.28	3,155.9	1,976.48	11,376.75	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	780	2,626	3,038	2,026	900	504	415	302
Diluted Enterprise Value	- -	722	2,503	2,909	1,926	940	516	430	334
EV per Share	- -	23.43	22.14	19.73	12.23	3.41	1.11	1.18	0.64
TTM Sales	- -	- -	- -	- -	114	- -	- -	- -	- -
TTM EBITDA	- -	-191	-197	-251	-170	-321	-300	-244	-195
TTM Operating Income	- -	-193	-202	-258	-180	-336	-314	-257	-207
TTM Cash Flow to Firm	- -	-41	-137	-115	-185	-221	-238	-200	-148
TTM Free Cash Flow to Firm	- -	-38	-87	-49	-163	-215	-236	-199	-148

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-18.82	-30.33	-61.83	-12.4	-4.18	-2.13	-2.08	-2.03
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	2,847	2,751	2,771	1,744	492	188	250	147
Low Price	- -	21.67	24.6	17.43	12.9	5.56	2.23	1.78	0.86
EV/Sales	- -	- -	- -	- -	15.28	3,155.9	1,976.48	11,376.75	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-3.64	-15.45	-12.41	-19.25	-4.44	-2.28	-2.31	-1.65
Price/Earnings High	- -	-4.87	-18.5	-20.93	-29.19	-7.35	-4.05	-4.37	-4.37
Price/Earnings Low	- -	-2.97	-13.47	-6.63	-9.62	-2.34	-1.07	-1.35	-1
Price/Book Value	- -	4.65	5.13	3.28	2.3	1.36	1.06	1.07	1.07
Price/Book Value Average	- -	4.59	5.57	4.25	3.98	2.29	1.56	1.53	1.12
Price/Book Value High	- -	6.14	6.68	7.16	6.03	3.79	2.78	2.91	2.96
Price/Book Value Low	- -	3.74	4.86	2.27	1.99	1.2	0.73	0.89	0.68
Price/Tangible Book Value	- -	4.66	5.13	3.28	2.3	1.36	1.06	1.07	1.07
Price/Tangible Book Value Average	- -	4.59	5.58	4.25	3.98	2.29	1.56	1.53	1.12
Price/Tangible Book Value High	- -	6.15	6.68	7.16	6.03	3.79	2.78	2.91	2.96
Price/Tangible Book Value Low	- -	3.75	4.86	2.27	1.99	1.2	0.73	0.89	0.68
Price/Sales	- -	- -	- -	- -	17.76	5,771.77	5,302.64	18,861.32	- -
Price/Sales Average	- -	- -	- -	- -	30.72	9,684.48	7,848.01	27,016.08	- -
Price/Sales High	- -	- -	- -	- -	46.57	16,049	13,942.15	51,182.36	- -
Price/Sales Low	- -	- -	- -	- -	15.36	5,101.91	3,683.77	15,762.04	- -
Price/Cash Flow	- -	-17.46	-19.12	-26.4	-10.96	-4.08	-2.12	-2.07	-2.03
Price/Cash Flow Average	- -	-17.22	-20.76	-34.12	-18.96	-6.85	-3.14	-2.97	-2.11
Price/Cash Flow High	- -	-23.05	-24.87	-57.52	-28.75	-11.35	-5.57	-5.62	-5.59
Price/Cash Flow Low	- -	-14.05	-18.1	-18.23	-9.48	-3.61	-1.47	-1.73	-1.27
Price/Free Cash Flow Average	- -	-18.57	-32.94	-79.92	-21.45	-7.02	-3.16	-2.98	-2.11
Price/Free Cash Flow High	- -	-24.85	-39.46	-134.74	-32.52	-11.63	-5.61	-5.64	-5.6
Price/Free Cash Flow Low	- -	-15.15	-28.72	-42.7	-10.72	-3.7	-1.48	-1.74	-1.28
EV/Sales Average	- -	- -	- -	- -	31.38	10,023.24	8,559.6	30,135.18	- -
EV/Sales High	- -	- -	- -	- -	48.03	16,445.17	15,108.49	56,459.78	- -
EV/Sales Low	- -	- -	- -	- -	15.25	5,399.34	4,084.61	17,876.04	- -
EV/EBITDA Average	- -	-16.56	-17.18	-17.77	-21.09	-4.87	-2.71	-2.72	-1.84
EV/EBITDA High	- -	-22.27	-20.7	-30.31	-32.28	-7.99	-4.78	-5.09	-4.62
EV/EBITDA Low	- -	-13.46	-14.9	-9.25	-10.25	-2.62	-1.29	-1.61	-1.18
EV/EBIT Average	- -	-16.44	-16.75	-17.25	-19.87	-4.66	-2.59	-2.57	-1.73
EV/EBIT High	- -	-22.09	-20.19	-29.42	-30.41	-7.65	-4.56	-4.82	-4.34
EV/EBIT Low	- -	-13.35	-14.53	-8.98	-9.65	-2.51	-1.23	-1.53	-1.11
Last Price	- -	26.93	25.98	25.24	14.92	6.29	3.21	2.13	1.37
High Price	- -	35.55	33.8	55	39.12	17.49	8.44	5.78	3.78
Enterprise Value Average	- -	3,170	3,384	4,453	3,580	1,564	813	663	358
Enterprise Value High	- -	4,261	4,078	7,597	5,479	2,565	1,435	1,242	899
Enterprise Value Low	- -	2,575	2,935	2,319	1,740	842	388	393	229

Shares Outstanding	114	121	124	140	143	144	169	212	229
Diluted Weighted Avg Shares	- -	29	101	120	136	143	157	195	221
Basic Weighted Avg Shares	- -	29	101	120	136	143	157	195	221
Revenue per Share	- -	- -	- -	- -	0.84	- -	- -	- -	- -
EBITDA per Share	- -	-6.61	-1.95	-2.08	-1.25	-2.24	-1.91	-1.25	-0.88
Operating Income per Share	- -	-6.66	-2	-2.15	-1.33	-2.34	-2	-1.32	-0.94
Basic EPS, GAAP	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Basic EPS from Cont Ops	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Diluted EPS, GAAP	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Diluted EPS from Cont Ops	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-1.54	-1.36	-0.96	-1.36	-1.54	-1.51	-1.03	-0.68
Free Cash Flow per Basic Share	- -	-1.65	-1.86	-1.5	-1.52	-1.58	-1.52	-1.03	-0.68
Cash & Equivalents per Share	- -	3.78	4.27	5.89	3.21	3.58	2.66	1.38	1.09
Book Value per Share	- -	5.79	5.06	7.69	6.49	4.62	3.04	1.99	1.28
Tangible Book Value per Share	- -	5.78	5.06	7.69	6.49	4.62	3.04	1.99	1.28

Allogene Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)